Johnson Pharmacare Ltd
Johnson Pharmacare Ltd (JOHNPHARMA) last traded at ₹0.47, a market capitalisation of ₹25.8 crore. Over the past 52 weeks the stock has ranged between ₹0.45 and ₹0.85. Johnson Pharmacare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-1.1 crore. Figures are as of 25 Aug 2026 and are not real time.
Johnson Pharmacare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Johnson Pharmacare Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0.03 | 0.01 | 0.05 | 0 | 0.02 | 42.7 | 0.04 |
| Operating profit | 0 | -0.03 | -0.01 | -0.05 | 0 | -0.02 | -42.7 | -0.04 |
| OPM % | — | — | — | — | — | — | — | — |
| Other income | 0 | 0 | -0.5 | 0 | 0 | 0 | -12.69 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.22 | 1.06 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -0.03 | -0.51 | -0.05 | 0 | -0.06 | -55.61 | -1.1 |
| Tax % | — | 0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% |
| Net profit | 0 | -0.03 | -0.51 | -0.05 | 0 | -0.06 | -55.61 | -1.1 |
| EPS (₹) | 0.00 | -0.00 | -0.01 | -0.00 | 0.00 | -0.00 | -1.01 | -0.02 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Johnson Pharmacare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1 | 3 | 3 | 0 | 0 | 0 | 0 |
| Operating profit | 0 | 0 | 0 | -0 | -0 | -43 | -43 |
| OPM % | 0.0% | 4.0% | 9% | — | — | — | — |
| Net profit | 0 | 0 | -1 | -0 | -1 | -56 | -57 |
| EPS (₹) | 0.00 | 0.00 | -0.02 | -0.00 | -0.01 | -1.01 | -1.03 |
TTM is the trailing twelve months to the most recent quarter.
Johnson Pharmacare Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -10019%
- 10 Years
- 1%
- 5 Years
- 11%
- 3 Years
- -2%
- 1 Year
- -40%
- 10 Years
- -8%
- 5 Years
- -16%
- 3 Years
- -30%
- Last Year
- -146%
Johnson Pharmacare Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Public | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% |
| No. of shareholders | 1,17,397 | 1,17,101 | 1,17,105 | 1,17,098 | 1,17,101 | 1,17,101 | 1,17,101 | 1,17,101 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Johnson Pharmacare Ltd corporate filings
- Pursuant to regulation 47 of LODR, 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June, 2026.Company Updatehigh impact
Cruxal's analysis: Johnson Pharmacare Limited has reported its unaudited financial results for the quarter…
Read the full analysis - Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015Company Updatelow impact
Cruxal's analysis: Johnson Pharmacare Ltd has submitted an undertaking confirming that Regulation 32 of the…
Read the full analysis - Submission of Un-Audited Financial Results for the Quarter ended on June 30th 2026 and along with Limited Review Report Thereon.Resultlow impact
Cruxal's analysis: Johnson Pharmacare Limited reported nil revenue from operations for the quarter ended…
Read the full analysis - UN-AUDITED FINANCIAL RESULTS The Board of Director have considered and approved the Un-Audited Financial Results along with Limited Review Report thereon for quarter ended on June 30th, ....Board Meetinglow impact
Cruxal's analysis: Johnson Pharmacare Limited has released its unaudited financial results for the quarter…
Read the full analysis - The Exchange and Investors are hereby informed that boards of directors of the company had accorded thier approval for shifting of Registered Office of the Company from Existing Address ....Company Updatelow impact
Cruxal's analysis: Johnson Pharmacare Ltd has received board approval to shift its registered office from…
Read the full analysis - Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve To consider and approve ....Board Meetinglow impact
Cruxal's analysis: Johnson Pharmacare Limited has issued a formal intimation regarding a board meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Johnson Pharmacare Ltd
Cruxal reads every Johnson Pharmacare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.